Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02536118 · ClinicalTrials.gov registry record

Micra Transcatheter Pacing System Post-Approval Registry

A clinical trial of Bradycardia, sponsored by Medtronic.

Active
Registry status
3,100
Enrollment target
20
Study locations

NCT02536118 is a study of Bradycardia that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 3,100 participants, below the 4,306-participant average among 29 other Bradycardia trials with a reported enrollment target (28% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02536118, a study of Bradycardia, is active but no longer recruiting, sponsored by Medtronic.

ACTIVE NOT RECRUITING
Registry status
3,100 participants
Enrollment target
20
Study locations

Study Summary

Medtronic is sponsoring the Micra Registry to further confirm safety and effectiveness of the Micra Transcatheter Pacing System (Micra system) when used as intended, in "real-world" clinical practice, following commercial release. The Micra Registry is conducted within Medtronic's Product Surveillance Registry.

Conditions Studied

Interventions

  • DEVICE Micra Transcatheter Pacing System

Study Locations (20)

Florida

  • - Clearwater
  • - Jacksonville
  • - Safety Harbor

Maryland

  • - Salisbury
  • - Silver Spring
  • - Takoma Park

California

  • - Los Angeles
  • - Redwood City

Kentucky

  • - Edgewood
  • - Louisville

Michigan

  • - Ann Arbor
  • - Lansing

Alabama

  • - Birmingham

Connecticut

  • - New Haven

District of Columbia

  • - Washington D.C.

Trial Details

FieldValue
Enrollment Target 3,100 participants
Start Date 2015-07
Est. Completion 2027-04

Sponsor

Medtronic

30 total trials

What the Registry Record Tells You About NCT02536118

The ClinicalTrials.gov registry entry for NCT02536118 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,306-participant average among 29 other Bradycardia trials with a reported enrollment target (28% lower). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Micra Transcatheter Pacing System is the first listed.

NCT02536118 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Maryland, California.

Frequently Asked Questions

What is clinical trial NCT02536118 about?

NCT02536118 is a clinical study titled "Micra Transcatheter Pacing System Post-Approval Registry". Medtronic is sponsoring the Micra Registry to further confirm safety and effectiveness of the Micra Transcatheter Pacing System (Micra system) when used as intended, in "real-world" clinical practice, following commercial release. The Micra Registry is conducted within Medtronic's Product Surveilla...

What is the current status of trial NCT02536118?

This trial is currently active not recruiting. The enrollment target is 3,100 participants. The study started on 2015-07. Estimated completion is 2027-04.

What conditions does trial NCT02536118 study?

This clinical trial studies the following conditions: Bradycardia.

What interventions are being tested in trial NCT02536118?

The interventions under investigation include: Micra Transcatheter Pacing System (DEVICE).

Who is sponsoring clinical trial NCT02536118?

This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02536118 being conducted?

This trial has 20 study locations across Alabama, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.